Study | Arms | Demographic characteristics | Number of patients | Mortality | Primary outcome (mortality) | Study design | |||||
---|---|---|---|---|---|---|---|---|---|---|---|
Population | Country | Clinical setting | Centre | EGDT | UC/LGT | EGDT (%) | UC/LGT (%) | ||||
Rivers 2001 [4] | EGDT/UC | Adult | USA | ED | S | 130 | 133 | 29.2 | 44.5 | In-hospital | RCT |
Lin 2006 [31] | EGDT/UC | Adult | Taiwan | ICU | S | 108 | 116 | 53.7 | 71.6 | In-hospital | RCT |
Wang 2006 [32] | EGDT/UC | Adult | China | ICU | S | 16 | 17 | 25.0 | 41.2 | 14-day | RCT |
Chen 2007 [29] | EGDT/UC | Adult | China | ICU | S | 88 | 102 | 29.5 | 49.0 | In-hospital | RCT |
He 2007 [30] | EGDT/UC | Adult | China | ICU | S | 98 | 105 | 52.0 | 64.8 | In-hospital | RCT |
Yan 2010 [27] | EGDT/UC | Adult | China | ICU | M | 157 | 146 | 35.0 | 50.7 | 28-day | RCT |
Andrews 2014 [28] | EGDT/UC | Adult | Zambia | ED/ICU | S | 53 | 56 | 64.2 | 60.7 | In-hospital | RCT |
ARISE 2014 [7] | EGDT/UC | Adult | Australasia/New Zealand | ED | M | 792 | 796 | 18.6 | 18.8 | 90-day | RCT |
ProCESS 2014 [6] | EGDT/UC | Adult | USA | ED/ICU | M | 439 | 456 | 21.0 | 18.9 | 60-day | RCT |
ProMISe 2015 [8] | EGDT/UC | Adult | England | ED | M | 623 | 620 | 29.5 | 29.2 | 90-day | RCT |
Jansen 2010 [14] | EGDT/LGT | Adult | Netherlands | ICU | M | 177 | 171 | 43.5 | 33.9 | In-hospital | RCT |
Jones 2010 [15] | EGDT/LGT | Adult | USA | ED | M | 150 | 150 | 23.0 | 17.0 | In-hospital | RCT |
Tian 2012 [17] | EGDT/LGT | Adult | China | ICU | S | 19 | 43 | 63.2 | 32.6 | 28-day | RCT |
Yu 2013 [13] | EGDT/LGT | Adult | China | ICU | S | 25 | 25 | 28.0 | 20.0 | 28-day | RCT |
Wang 2014 [18] | EGDT/LGT | Adult | China | ICU | S | 31 | 26 | 54.8 | 26.9 | 28-day | RCT |
Lv 2015 [16] | EGDT/LGT | Adult | China | ICU | S | 50 | 50 | 56.0 | 40.0 | 28-day | RCT |